DM Capital

DM Capital Ltd. is a venture capital and private equity firm founded in 2001 and headquartered in Shenzhen, China, with additional offices in major cities including Beijing, Guangzhou, and Zurich. The firm specializes in early-stage and growth investments, primarily focusing on the healthcare sector. Its investment interests encompass a wide range of areas such as innovative medical technologies, artificial intelligence, biomedicine, genetic technology, and advanced healthcare equipment. DM Capital also engages in industrial investments and provides financial advisory services. As the parent company of DM Healthcare Investment Co., Ltd., it further extends its investment activities to overseas healthcare industries. The firm is committed to fostering technology innovation and creating value through strategic investments in companies involved in health technology, biopharmaceuticals, and medical devices. Through its subsidiary, DM Fund Management Limited, DM Capital actively manages funds that target public Chinese companies listed on international exchanges, while also facilitating mergers and acquisitions between Chinese and Western markets.

Fredrik Edstrom

Managing Partner

Jason Gu

Managing Partner and Manager of Direct Investment Department

Li Jun

Founding Partner and President

Kelly Li

Co-Founder, Managing Partner and Chairman

Tim Lin

Managing Partner

Thomas Werder

Partner, Europe

Terry Zhang

Director of Trading and Managing Partner

Jessie Zhao

Co-Founder and Managing Partner

Hans Zhou

Fund Manager of Harmony Fund, CEO and Managing Partner

3 past transactions

Rege Nephro

Venture Round in 2022
Rege Nephro Co., Ltd. engages in the research and development, production, and marketing of renal disease therapeutics using nephron progenitor cells. It also produces kidney organoids capable of nephrotoxicity screening for drug discovery in applied research. The company was founded in 2019 and is based in Kyoto, Japan.

eBrace

Series A in 2014
Guangzhou eBrace Biotechnology Co., Ltd. specializes in the research, development, production, and sale of orthodontic biological materials and digital 3D printing technologies. Founded in 2010 and headquartered in Guangzhou, China, the company offers a range of products including 3D custom printed orthodontic teeth, dentures, and personalized lingual and bracketless invisible appliances. eBrace is committed to providing detailed and accurate dental solutions, leveraging advanced 3D printing equipment to meet the needs of its customers in the orthodontics sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.